Jiming Huang / Blog
October 2019 marked a milestone for modern genetic medicine. A leading Swiss drug maker registered USD 160 million of quarterly sales for the world's most expensive drug – Zolgensma – a gene therapy priced at USD 2.1 million...
Impeachment. The House Intelligence Committee held more closed hearings this week as part of the ongoing impeachment inquiry. The process will move to a more public phase next week when the committee initiates open hearings that will feature witnesses who have already testified privately...
Pivot (invalidation): 56.65 Our preference Long positions above 56.65 with targets at 57.15 & 57.45 in extension. Alternative scenario...
Pivot (invalidation): 16.7500 Our preference Long positions above 16.7500 with targets at 16.9800 & 17.0900 in extension. Alternative scenario...
Pivot (invalidation): 1459.00 Our preference Long positions above 1459.00 with targets at 1468.00 & 1472.50 in extension. Alternative scenario...
Pivot (invalidation): 3080.00 Our preference Long positions above 3080.00 with targets at 3098.00 & 3109.00 in extension. Alternative scenario...
Pivot (invalidation): 13270.00 Our preference Short positions below 13270.00 with targets at 13180.00 & 13120.00 in extension...
Pivot (invalidation): 5.7580 Our preference Long positions above 5.7580 with targets at 5.7765 & 5.7860 in extension. Alternative scenario...
Pivot (invalidation): 0.6870 Our preference Short positions below 0.6870 with targets at 0.6845 & 0.6830 in extension. Alternative scenario...